Suicidality risk after using cannabis and cannabinoids: An umbrella review

References

• Armoon B, SoleimanvandiAzar N, Fleury M-J, Noroozi A, Bayat A-H, Mohammadi R, Ahounbar E, Fattah Moghaddam L. 2021. Prevalence, sociodemographic variables, mental health condition, and type of drug use associated with suicide behaviors among people with substance use disorders: a systematic review and meta-analysis. J Addict Dis. 39(4):550–569. doi: 10.1080/10550887.2021.1912572.
   PubMed Web of Science ®Google Scholar
• Bagge CL, Borges G. 2017. Acute substance use as a warning sign for suicide attempts: a case-crossover examination of the 48 hours prior to a recent suicide attempt. J Clin Psychiatry. 78(06):691–696. doi: 10.4088/JCP.15m10541.
   PubMedGoogle Scholar
• Bahji A, Danilewitz M, Vazquez G, Patten S. 2021. The prevalence of cannabis use disorder comorbidity in individuals with bipolar disorder: a systematic review and meta-analysis. Canadian J Addict. 12(3):22–38. doi: 10.1097/CXA.0000000000000123.
   Web of Science ®Google Scholar
• Bartoli F, Crocamo C, Carrà G. 2019. Cannabis use disorder and suicide attempts in bipolar disorder: a meta-analysis. Neurosci Biobehav Rev. 103:14–20. doi: 10.1016/j.neubiorev.2019.05.017.
   PubMed Web of Science ®Google Scholar
• Borges G, Bagge CL, Orozco R. 2016. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 195:63–74. doi: 10.1016/j.jad.2016.02.007.
   PubMed Web of Science ®Google Scholar
• Breet E, Goldstone D, Bantjes J. 2018. Substance use and suicidal ideation and behaviour in low- and middle-income countries: a systematic review. BMC Public Health. 18(1). doi: 10.1186/s12889-018-5425-6. https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-018-5425-6#citeas
   PubMedGoogle Scholar
• Calabria B, Degenhardt L, Hall W, Lynskey M. 2010. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev. 29(3):318–330. doi: 10.1111/j.1465-3362.2009.00149.x.
   PubMed Web of Science ®Google Scholar
• Campeny E, López-Pelayo H, Nutt D, Blithikioti C, Oliveras C, Nuño L, Maldonado R, Florez G, Arias F, Fernández-Artamendi S, et al. 2020. The blind men and the elephant: systematic review of systematic reviews of cannabis use related health harms. Eur Neuropsychopharmacol. 33:1–35. doi: 10.1016/j.euroneuro.2020.02.003.
   PubMed Web of Science ®Google Scholar
• Carrà G, Bartoli F, Crocamo C, Brady KT, Clerici M. 2014. Attempted suicide in people with co-occurring bipolar and substance use disorders: systematic review and meta-analysis. J Affect Disord. 167:125–135. doi: 10.1016/j.jad.2014.05.066.
   PubMed Web of Science ®Google Scholar
• Carvalho JV, Souza LS, Moreira EC. 2022. Association between cannabis use and suicidal behavior: a systematic review of cohort studies. Psychiatry Res. 312:114555. doi: 10.1016/j.psychres.2022.114555.
   PubMed Web of Science ®Google Scholar
• Chapman C, Slade T, Swift W, Keyes K, Tonks Z, Teesson M. 2017. Evidence for sex convergence in prevalence of cannabis use: a systematic review and meta-regression. J Stud Alcohol Drugs. 78(3):344–352. doi: 10.15288/jsad.2017.78.344.
   PubMed Web of Science ®Google Scholar
• Chiappini S, Mosca A, Miuli A, Santovito MC, Orsolini L, Corkery JM, Guirguis A, Pettorruso M, Martinotti G, Di Giannantonio M, et al. 2021. New psychoactive substances and suicidality: a systematic review of the current literature. Medicina. 57(6):580. doi: 10.3390/medicina57060580.
   PubMedGoogle Scholar
• Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O'Leary C, Ratcliffe S, Nováková I, et al. 2010. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis. Neurol Res. 32(5):451–459. doi: 10.1179/016164109X12590518685660.
   PubMed Web of Science ®Google Scholar
• Conner KR, Goldston DB. 2007. Rates of suicide among males increase steadily from age 11 to 21: developmental framework and outline for prevention. Aggres Violent Behav. 12(2):193–207. doi: 10.1016/j.avb.2006.07.002.
   Web of Science ®Google Scholar
• Crean RD, Crane NA, Mason BJ. 2011. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 5(1):1–8. doi: 10.1097/ADM.0b013e31820c23fa.
   PubMed Web of Science ®Google Scholar
• Darke S, Duflou J, Torok M. 2009. Toxicology and circumstances of completed suicide by means other than overdose. J Forensic Sci. 54(2):490–494. doi: 10.1111/j.1556-4029.2008.00967.x.
   PubMed Web of Science ®Google Scholar
• De Wit H. 2009. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict Biol. 14(1):22–31. doi: 10.1111/j.1369-1600.2008.00129.x.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W, Lynskey M. 2003. Exploring the association between cannabis use and depression. Addiction. 98(11):1493–1504. doi: 10.1046/j.1360-0443.2003.00437.x.
   PubMed Web of Science ®Google Scholar
• Doucette ML, Borrup KT, Lapidus G, Whitehill JM, McCourt AD, Crifasi CK. 2021. Effect of Washington State and Colorado’s cannabis legalization on death by suicides. Prev Med. 148:106548. doi: 10.1016/j.ypmed.2021.106548.
   PubMed Web of Science ®Google Scholar
• Escelsior A, Belvederi Murri M, Corsini GP, Serafini G, Aguglia A, Zampogna D, Cattedra S, Nebbia J, Trabucco A, Prestia D, et al. 2021. Cannabinoid use and self-injurious behaviours: a systematic review and meta-analysis. J Affect Disord. 278:85–98. doi: 10.1016/j.jad.2020.09.020.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Boden JM, Horwood LJ. 2006. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 101(4):556–569. doi: 10.1111/j.1360-0443.2005.01322.x.
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Swain‐Campbell N. 2002. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction. 97(9):1123–1135. doi: 10.1046/j.1360-0443.2002.00103.x.
   PubMed Web of Science ®Google Scholar
• Fresán A, Dionisio-García DM, González-Castro TB, Ramos-Méndez M, Castillo-Avila RG, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez ML, Genis-Mendoza AD, Nicolini H. 2022. Cannabis smoking increases the risk of suicide ideation and suicide attempt in young individuals of 11–21 years: a systematic review and meta-analysis. J Psychiatr Res. 153:90–98. doi: 10.1016/j.jpsychires.2022.06.053.
   PubMed Web of Science ®Google Scholar
• Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, et al. 2019. Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiatry. 76(4):426. doi: 10.1001/jamapsychiatry.2018.4500.
   PubMed Web of Science ®Google Scholar
• Hodgson K, Almasy L, Knowles EEM, Kent JW, Curran JE, Dyer TD, Göring HHH, Olvera RL, Woolsey MD, Duggirala R, et al. 2017. The genetic basis of the comorbidity between cannabis use and major depression. Addiction. 112(1):113–123. doi: 10.1111/add.13558.
   PubMed Web of Science ®Google Scholar
• Ilgen MA, Burnette ML, Conner KR, Czyz E, Murray R, Chermack S. 2010. The association between violence and lifetime suicidal thoughts and behaviors in individuals treated for substance use disorders. Addict Behav. 35(2):111–115. doi: 10.1016/j.addbeh.2009.09.010.
   PubMed Web of Science ®Google Scholar
• Karanikola M, Zisimou P, Nystazaki M, Koutrouba A, Severinsson E. 2019. Association between illegal use of substances and suicidal behavior in school students: an integrative review of empirical data. J Child Adolesc Psychiatr Nurs. 32(2):80–101. doi: 10.1111/jcap.12228.
   PubMed Web of Science ®Google Scholar
• Klein P, Devinsky O, French J, Harden C, Krauss GL, McCarter R, Sperling MR. 2021. Suicidality risk of newer antiseizure medications: a meta-analysis. JAMA Neurol. 78(9):1118–1127. doi: 10.1001/jamaneurol.2021.2480.
   PubMed Web of Science ®Google Scholar
• Kung H-C, Pearson JL, Liu X. 2003. Risk factors for male and female suicide decedents ages 15–64 in the United States. Soc Psychiatry Psychiatr Epidemiol. 38(8):419–426. doi: 10.1007/s00127-003-0656-x.
   PubMed Web of Science ®Google Scholar
• Lynskey M, Hall W. 2000. The effects of adolescent cannabis use on educational attainment: a review. Addiction. 95(11):1621–1630. doi: 10.1046/j.1360-0443.2000.951116213.x.
   PubMed Web of Science ®Google Scholar
• Lynskey MT, Glowinski AL, Todorov AA, Bucholz KK, Madden PA, Nelson EC, Statham DJ, Martin NG, Heath AC. 2004. Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry. 61(10):1026–1032. doi: 10.1001/archpsyc.61.10.1026.
   PubMed Web of Science ®Google Scholar
• Macleod J, Oakes R, Copello A, Crome L, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Smith GD. 2004. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 363(9421):1579–1588. doi: 10.1016/S0140-6736(04)16200-4.
   PubMed Web of Science ®Google Scholar
• Mark Anderson D, Hansen B, Rees DI. 2015. Medical marijuana laws and teen marijuana use. Am Law Econ Rev. 17(2):495–528. doi: 10.1093/aler/ahv002.
   Web of Science ®Google Scholar
• Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. 2007. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review [Article]. Lancet. 370(9584):319–328. doi: 10.1016/S0140-6736(07)61162-3.
   PubMed Web of Science ®Google Scholar
• Otten R, Engels RC. 2013. Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addict Biol. 18(5):826–835. doi: 10.1111/j.1369-1600.2011.00380.x.
   PubMed Web of Science ®Google Scholar
• Pieper D, Antoine SL, Mathes T, Neugebauer EA, Eikermann M. 2014. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 67(4):368–375. doi: 10.1016/j.jclinepi.2013.11.007.
   PubMed Web of Science ®Google Scholar
• Pinto JV, Medeiros LS, Santana da Rosa G, Santana de Oliveira CE, Crippa JAS, Passos IC, Kauer-Sant’Anna M. 2019. The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: a systematic review with meta-analysis and meta-regression. Neurosci Biobehav Rev. 101:78–84. doi: 10.1016/j.neubiorev.2019.04.004.
   PubMed Web of Science ®Google Scholar
• Rioux C, Huet A-S, Castellanos-Ryan N, Fortier L, Le Blanc M, Hamaoui S, Geoffroy M-C, Renaud J, Seguin JR. 2021. Substance use disorders and suicidality in youth: a systematic review and meta-analysis with a focus on the direction of the association. PLOS One. 16(8):e0255799. doi: 10.1371/journal.pone.0255799.
   PubMed Web of Science ®Google Scholar
• Rudd MD, Berman AL, Joiner TE, Jr Nock MK, Silverman MM, Mandrusiak M, Van Orden K, Witte T. 2006. Warning signs for suicide: theory, research, and clinical applications. Suicide Life Threat Behav. 36(3):255–262. doi: 10.1521/suli.2006.36.3.255.
   PubMed Web of Science ®Google Scholar
• Schaffer A, Isometsä ET, Tondo L, D HM, Turecki G, Reis C, Cassidy F, Sinyor M, Azorin JM, Kessing LV, et al. 2015. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord. 17(1):1–16. doi: 10.1111/bdi.12271.
   PubMed Web of Science ®Google Scholar
• Schmidt K, Tseng I, Phan A, Fong T, Tsuang J. 2020. A systematic review: adolescent cannabis use and suicide. Addict Disord Treat. 19(3):146–151. doi: 10.1097/ADT.0000000000000196.
   Web of Science ®Google Scholar
• Serafini G, Pompili M, Innamorati M, Rihmer Z, Sher L, Girardi P. 2012. Can cannabis increase the suicide risk in psychosis? A critical review. Curr Pharm Des. 18(32):5165–5187. doi: 10.2174/138161212802884663.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. 2017. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both BMJ 2017; 358 :j4008 doi: 10.1136/bmj.j4008.
   Google Scholar
• Sher L, Oquendo MA. 2023. Suicide: An Overview for Clinicians. Medical Clinics of North America. 107(1):119–130. https://www.sciencedirect.com/science/article/abs/pii/S0025712522000402?via%3Dihub
   Google Scholar
• Shi Y, Lenzi M, An R. 2015. Cannabis liberalization and adolescent cannabis use: a cross-national study in 38 countries. PLOS One. 10(11):e0143562. doi: 10.1371/journal.pone.0143562.
   PubMed Web of Science ®Google Scholar
• Sideli L, Quigley H, La Cascia C, Murray RM. 2020. Cannabis use and the risk for psychosis and affective disorders. J Dual Diagn. 16(1):22–42. doi: 10.1080/15504263.2019.1674991.
   PubMed Web of Science ®Google Scholar
• Smith PA, Slaven M, Shaw E, Chow E, Wolt A. 2017. Medical cannabis use in military and police veterans diagnosed with post-traumatic stress disorder (PTSD). J Pain Manag. 10(4):397–405.
   Google Scholar
• Solowij N, Michie PT. 2007. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiat Neurosci. 32(1):30–52.
   PubMed Web of Science ®Google Scholar
• Stringer S, Minică CC, Verweij KJ, Mbarek H, Bernard M, Derringer J, van Eijk KR, Isen JD, Loukola A, Maciejewski DF et al. 2016. Genome-wide association study of lifetime cannabis use based on a large metaanalytic sample of 32 330 subjects from the International Cannabis Consortium. Transl Psychiatry. 6(3):e769. eng. https://pubmed.ncbi.nlm.nih.gov/27023175/
   Google Scholar
• Substance Abuse and Mental Health Services Administration. 2010. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings). Rockville, MD.
   Google Scholar
• Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. 2016. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol. 54(1):1–13. doi: 10.3109/15563650.2015.1110590.
   PubMed Web of Science ®Google Scholar
• Thabet P, Joshi A, MacDonald E, Hutton B, Cheng W, Stevens A, Kanji S. 2021. Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: an overview of systematic reviews. PLOS One. 16(1):e0244966. doi: 10.1371/journal.pone.0244966.
   PubMed Web of Science ®Google Scholar
• Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, et al. 2023. Canadian Network for Mood and Anxiety Treatments (CANMAT) task force report: a systematic review and recommendations of cannabis use in bipolar disorder and major depressive disorder. Can J Psychiatry. 68(5):299–311. doi: 10.1177/07067437221099769.
   PubMed Web of Science ®Google Scholar
• Turna J, MacKillop J. 2021. Cannabis use among military veterans: a great deal to gain or lose?. Clin Psychol Rev. 84:101958. doi: 10.1016/j.cpr.2021.101958.
   PubMed Web of Science ®Google Scholar
• Weeks M, Colman I. 2017. Predictors of suicidal behaviors in Canadian adolescents with no recent history of depression. Arch Suicide Res. 21(2):354–364. doi: 10.1080/13811118.2016.1193076.
   PubMed Web of Science ®Google Scholar
• Welty L, Harrison A, Abram K, Olson N, Aaby D, McCoy K. 2019. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 national survey on drug use and health (HHS Publication No. SMA 17-5044, NSDUH Series H-52). Rockville, MD: Center for Behavioral Health Statistics and Quality. (Substance Abuse and Mental Health Services Administration Retrieved College of Health Sciences. 106(5):128).
   Google Scholar
• Whitlow CT, Liguori A, Livengood LB, Hart SL, Mussat-Whitlow BJ, Lamborn CM, Laurienti PJ, Porrino LJ. 2004. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 76(1):107–111. doi: 10.1016/j.drugalcdep.2004.04.009.
   PubMed Web of Science ®Google Scholar